Survival among advanced non-small cell lung cancer patients with poor performance status after first-line chemotherapy

被引：0
|
作者：
Salloum, Ramzi George
Smith, Thomas J.
Jensen, Gail
Elston-Lafata, Jennifer
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA
[3] Wayne State Univ, Detroit, MI USA
[4] Virginia Commonwealth Univ, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18144
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cigarette smoking as a strong prognostic factor after first-line chemotherapy in advanced non-small cell lung cancer
    de Lima Araujo, L.
    Melo, A. C.
    Small, I. A.
    Ferreira, C. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Survival benefit from maintenance therapy after first-line chemotherapy in advanced non-small cell lung cancer: A meta-analysis.
    Chouahnia, Kader
    Guetz, Gaetan Des
    Uzzan, Bernard
    Nicolas, Patrick
    Morere, Jean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer
    Jiang, Haiping
    Zhang, Xiaochen
    Chen, Jing
    Zhang, Ling
    Xiong, Jianping
    Zhong, Lin
    Yu, Feng
    Qian, Jiong
    Yu, Lanfang
    Wang, Xiaoting
    Shi, Genming
    Deng, Jing
    Xu, Nong
    [J]. JOURNAL OF THORACIC DISEASE, 2014, 6 (02) : 79 - 85
  • [24] First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer A Systematic Review
    Goffin, John
    Lacchetti, Christina
    Ellis, Peter M.
    Ung, Yee C.
    Evans, William K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 260 - 274
  • [25] Prognosis of Advanced Non-Small Cell Lung Cancer (NSCLC) Refractory to First-Line Platinum Chemotherapy
    Ahn, Hee Kyung
    Kim, Young Saing
    Kim, Eun Young
    Kyung, Sun Young
    Kang, Shin Myung
    Cho, Eun Kyung
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S910 - S911
  • [26] New horizons in chemotherapy: Platforms for combinations in first-line advanced non-small cell lung cancer
    Lilenbaum, Rogerio C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : S171 - S174
  • [27] Single-agent compared to combination first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) of 2
    Bonomi, P.
    Villaflor, V. M.
    Oldham, F. B.
    Sandilac, L.
    Singer, J. W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma
    Vallejo, C
    Romero, A
    Perez, J
    Cuevas, M
    Lacava, J
    Sabatini, C
    Dominguez, M
    Rodriguez, R
    Barbieri, M
    Acuna, LR
    Acuna, JR
    Langhi, M
    Amato, S
    Salvadori, M
    Ortiz, E
    Machiavelli, M
    Leone, B
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (06): : 584 - 588
  • [29] First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
    Andric, Z. G.
    Galffy, G.
    Cobo Dols, M.
    Szima, B.
    Stojanovic, G.
    Petrovic, M. D.
    Felip Font, E.
    Vicente Baz, D.
    Ponce Aix, S.
    Juan-Vidal, O.
    Tehenes, S.
    Szalai, Z.
    Losonczy, G.
    Calles Blanco, A.
    Bernabe, R.
    Duecker, K.
    Zhou, D.
    Schroeder, A.
    Guezel, G.
    Ciardiello, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S753 - S754
  • [30] Neutropenia-Related Costs in Patients Treated with First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
    Stokes, Michael E.
    Muehlenbein, Catherine E.
    Marciniak, Martin D.
    Fairies, Douglas E.
    Motabar, Saeed
    Gillespie, Theresa W.
    Lipscomb, Joseph
    Knopf, Kevin B.
    Buesching, Don P.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (08): : 669 - 682
12345